Literature DB >> 15987273

Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats.

Eduardo Paulo Morowsky Vianna1, Alice Teixeira Ferreira, Flávia Doná, Esper Abrão Cavalheiro, Maria José da Silva Fernandes.   

Abstract

PURPOSE: Adenosine is a major negative neuromodulator of synaptic activity in the central nervous system and can exert anticonvulsant and neuroprotective effects in many experimental models of epilepsy. Extracellular adenosine can be formed by a membrane-anchored enzyme ecto-5'-nucleotidase. The purposes of this study were to characterize the role of adenosine receptors in modulating status epilepticus (SE) induced by pilocarpine and evaluate its neuroprotective action. Ecto-5'-nucleotidase activity was studied during the different phases of pilocarpine-induced epilepsy in rats.
METHODS: Adult rats were pretreated with different adenosinergic agents to evaluate the latency and incidence of SE induced by pilocarpine in rats. The neuroprotective effect also was evaluated.
RESULTS: A proconvulsant effect was observed with DPCPX and DMPX that reduced the latency of SE in almost all rats. Pretreatment with the MRS 1220 did not alter the incidence of SE but reduced the latency to develop SE. An anticonvulsant and neuroprotective effect was detected with R-PIA. Rats pretreated with R-PIA had a decreased number of apoptotic cells in the hippocampus, whereas pretreatment with DPCPX did not modify the hippocampal damage. An intensification of neuronal death was observed in the dentate gyrus and CA3 when rats were pretreated with DMPX. MRS-1220 did not modify the number of apoptotic cells in the hippocampus. An increase in the ecto-5 -nucleotidase staining was detected in the hippocampus during silent and chronic phases.
CONCLUSIONS: The present data show that adenosine released during pilocarpine-induced SE via A1-receptor stimulation can exhibit neuroprotective and anticonvulsant roles. Similar effects could also be inferred with A2a and A3 adenosinergic agents, but further experiments are necessary to confirm their roles. Ecto-5 -nucleotidase activity during silent and chronic phases might have a role in blocking spontaneous seizures by production of inhibitory neuromodulator adenosine, besides taking part in the mechanism that controls sprouting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987273     DOI: 10.1111/j.1528-1167.2005.01027.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  16 in total

1.  Gamma-Decanolactone Alters the Expression of GluN2B, A1 Receptors, and COX-2 and Reduces DNA Damage in the PTZ-Induced Seizure Model After Subchronic Treatment in Mice.

Authors:  Fernanda Marcelia Dos Santos; Pricila Fernandes Pflüger; Leticia Lazzarotto; Mariana Uczay; Wesley Roberto de Aguida; Lisiane Santos da Silva; Fernanda Brião Menezes Boaretto; Jayne Torres de Sousa; Jaqueline Nascimento Picada; Iraci Lucena da Silva Torres; Patrícia Pereira
Journal:  Neurochem Res       Date:  2021-05-21       Impact factor: 3.996

2.  Increased cortical extracellular adenosine correlates with seizure termination.

Authors:  Jamie J Van Gompel; Mark R Bower; Gregory A Worrell; Matt Stead; Su-Youne Chang; Stephan J Goerss; Inyong Kim; Kevin E Bennet; Fredric B Meyer; W Richard Marsh; Charles D Blaha; Kendall H Lee
Journal:  Epilepsia       Date:  2014-01-31       Impact factor: 5.864

3.  The adenosine A1 receptor agonist WAG 994 suppresses acute kainic acid-induced status epilepticus in vivo.

Authors:  Zin-Juan Klaft; Lina M Duerrwald; Zoltan Gerevich; Chris G Dulla
Journal:  Neuropharmacology       Date:  2020-06-29       Impact factor: 5.250

Review 4.  Modulators of nucleoside metabolism in the therapy of brain diseases.

Authors:  Detlev Boison
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

5.  Adenosine neuromodulation and traumatic brain injury.

Authors:  T A Lusardi
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 6.  Adenosine receptors and epilepsy: current evidence and future potential.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

7.  Variations of ATP and its metabolites in the hippocampus of rats subjected to pilocarpine-induced temporal lobe epilepsy.

Authors:  Flávia Doná; Isaltino Marcelo Conceição; Henning Ulrich; Eliane Beraldi Ribeiro; Thalma Ariani Freitas; Ana Leonor Abrahao Nencioni; Maria José da Silva Fernandes
Journal:  Purinergic Signal       Date:  2016-03-03       Impact factor: 3.765

8.  Adenosine A2A receptor deficient mice are partially resistant to limbic seizures.

Authors:  Malika El Yacoubi; Catherine Ledent; Marc Parmentier; Jean Costentin; Jean-Marie Vaugeois
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-06-02       Impact factor: 3.000

9.  The imbalanced expression of adenosine receptors in an epilepsy model corrected using targeted mesenchymal stem cell transplantation.

Authors:  Kang Huicong; Xue Zheng; Wang Furong; Tang Zhouping; Xu Feng; Hu Qi; Liu Xiaoyan; Huang Xiaojiang; Zhang Na; Xu Ke; Zeng Zheng; Zhu Suiqiang
Journal:  Mol Neurobiol       Date:  2013-06-20       Impact factor: 5.590

Review 10.  Role of Adenosine in Epilepsy and Seizures.

Authors:  Fabio C Tescarollo; Diogo M Rombo; Lindsay K DeLiberto; Denise E Fedele; Enmar Alharfoush; Ângelo R Tomé; Rodrigo A Cunha; Ana M Sebastião; Detlev Boison
Journal:  J Caffeine Adenosine Res       Date:  2020-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.